Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042863
Filing Date
2021-08-10
Accepted
2021-08-10 06:31:23
Documents
74
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dbtx-10q_20210630.htm   iXBRL 10-Q 3370473
2 EX-10.1 dbtx-ex101_119.htm EX-10.1 71696
3 EX-31.1 dbtx-ex311_8.htm EX-31.1 19394
4 EX-31.2 dbtx-ex312_6.htm EX-31.2 19434
5 EX-32.1 dbtx-ex321_9.htm EX-32.1 9262
6 EX-32.2 dbtx-ex322_7.htm EX-32.2 9544
7 GRAPHIC gvokexlzxsq0000001.jpg GRAPHIC 5726
  Complete submission text file 0001564590-21-042863.txt   10025953

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA dbtx-20210630.xsd EX-101.SCH 50320
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dbtx-20210630_cal.xml EX-101.CAL 40327
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dbtx-20210630_def.xml EX-101.DEF 174957
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE dbtx-20210630_lab.xml EX-101.LAB 370045
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dbtx-20210630_pre.xml EX-101.PRE 306722
13 EXTRACTED XBRL INSTANCE DOCUMENT dbtx-10q_20210630_htm.xml XML 1917246
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Filer) CIK: 0001656536 (see all company filings)

EIN.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40030 | Film No.: 211158361
SIC: 2834 Pharmaceutical Preparations